Global Hemostats Market: Product Type (Thrombin Based, Collagen Based, Tissue Sealants- Fibrin Sealants, and Others), Instrument Type (Halstead Mosquito Hemostatic Forceps,), Application (Gynecology, Neurology, Cardiovascular) -–Global Forecast Till 2023

ID: MRFR/MED/4952-HCR | February 2021 | Region: Global | 100 pages

The global hemostats market is expected to register a 6.4% growth during the forecast period (2018–2023). , Blood loss occurs in surgeries due to the damage of blood vessels. It is vital to coalesce the blood to avoid too much of blood loss. The formation of blood clots at the site of injury is called hemostasis. Hemostats are surgical tools that are used during surgeries to control the bleeding of the patient. These surgical instruments help to temporarily form blood clots to control bleeding. The hemostat is also known as a hemostatic clamp and arterial forceps. It is fundamentally used in the early phases of surgery for a preliminary incision that closes blood vessels till ligation. Tissue sealants and tissue adhesion agents are very helpful for the application of hemostats. , The growing number of surgical procedures, continuous progression in products range, rising incidences of sports-related damages, spinal disorders, technological advancements and increasing focus on effective blood loss management in patients during surgeries are the chief factors to boosts the hemostats market. Also, the emerging markets and rise in the number of hospitals and surgical centers are anticipated to offer added growth opportunities for players operating in the hemostats market. However, the high cost of hemostats, government’s rules and regulations and lack of skilled professionals is expected to hamper the growth of hemostats market., Segmentation, The global hemostats market has been segmented on the basis of product type, instrument type, application, and end-user., On the basis of product type, the market has been classified as thrombin-based, combination based, oxidized regenerated cellulose-based, gelatin based, collagen-based hemostat, tissue sealants, cyanoacrylate-based tissue adhesives, adhesion prevention products. The tissue sealants have been segmented into fibrin sealants, protein-based sealants. , On the basis of instrument type, the market has been classified as halstead mosquito hemostatic forceps, kelly and crile hemostatic forceps, and rochester-carmalt hemostatic forceps., On the basis of application, the market has been classified as cardiovascular surgery, general surgery, gynecological surgery, reconstructive surgery, neurological surgery, orthopedic surgery, and other surgeries., On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, community healthcare, and others., On

Market Scenario

The global hemostats market is expected to register a 6.4% growth during the forecast period (2018–2023).

Blood loss occurs in surgeries due to the damage of blood vessels. It is vital to coalesce the blood to avoid too much of blood loss. The formation of blood clots at the site of injury is called hemostasis. Hemostats are surgical tools that are used during surgeries to control the bleeding of the patient. These surgical instruments help to temporarily form blood clots to control bleeding. The hemostat is also known as a hemostatic clamp and arterial forceps. It is fundamentally used in the early phases of surgery for a preliminary incision that closes blood vessels till ligation. Tissue sealants and tissue adhesion agents are very helpful for the application of hemostats.

The growing number of surgical procedures, continuous progression in products range, rising incidences of sports-related damages, spinal disorders, technological advancements and increasing focus on effective blood loss management in patients during surgeries are the chief factors to boosts the hemostats market. Also, the emerging markets and rise in the number of hospitals and surgical centers are anticipated to offer added growth opportunities for players operating in the hemostats market. However, the high cost of hemostats, government’s rules and regulations and lack of skilled professionals is expected to hamper the growth of hemostats market.

Segmentation

The global hemostats market has been segmented on the basis of product type, instrument type, application, and end-user.

On the basis of product type, the market has been classified as thrombin-based, combination based, oxidized regenerated cellulose-based, gelatin based, collagen-based hemostat, tissue sealants, cyanoacrylate-based tissue adhesives, adhesion prevention products. The tissue sealants have been segmented into fibrin sealants, protein-based sealants.

On the basis of instrument type, the market has been classified as halstead mosquito hemostatic forceps, kelly and crile hemostatic forceps, and rochester-carmalt hemostatic forceps.

On the basis of application, the market has been classified as cardiovascular surgery, general surgery, gynecological surgery, reconstructive surgery, neurological surgery, orthopedic surgery, and other surgeries.

On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, community healthcare, and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European hemostats market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The hemostats market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hemostats market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Global Hemostats Market Share, by Region, 2017 (%)

Hemostats Market Share

Source: MRFR Analysis

In the hemostats market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. According to the National Health Statistics Report by the Centers of Disease Control & Prevention, in 2014, about 201,748.3 million surgical procedures were carried out in the U.S. The statistics also showed that 28.6 million appointments to ambulatory surgery cases were informed in the U.S.

The European market is expected to hold the second largest market share. The market growth in this region can be attributed to growing frequency of cardiovascular disorders, increasing number of surgeries and rising demand for advanced treatment procedures are boosting the European market.

The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.

The market in the Middle East and Africa is expected to account for the smallest share of the global hemostats market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Key Players

Some of the key players in the global hemostats market are CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US).

Global Hemostats Market, by Product Type

Thrombin based

Combination-based

Oxidized regenerated cellulose based

Gelatin-based

Collagen-based hemostat

Tissue sealant

Fibrin sealants

Protein-based sealants

Cyanoacrylate-based tissue adhesives

Adhesion prevention products

Global Hemostats Market, by Instrument Type

Halstead mosquito hemostatic forceps

Kelly and Crile hemostatic forceps

Rochester-carmalt hemostatic forceps

Global Hemostats Market, by Application Type

Cardiovascular surgery

General surgery

Gynecological surgery

Reconstructive surgery

Neurological surgery

Orthopedic surgery

Other surgeries

Global Hemostats Market, by End-Users

Hospitals

Clinics

Ambulatory surgery centers

Community healthcare

Others

Global Hemostats Market, by Region

Americas

North America

Canada

South America

Europe

Western Europe

Germany

France

Italy

Spain

Rest of Western Europe

Eastern Europe

Asia-Pacific

Japan

China

India

Australia

South Korea

Rest of Asia-Pacific

Middle East & Africa

Middle East

Africa

Intended Audience

Advanced Surgical Trainees

Governmental Agency

Educational Organizations

Medical Device Manufacturers

Research Institutes and Academic Centers

Market Research and Consulting

Frequently Asked Questions (FAQ) :

What are Hemostats?

Hemostats are surgical tools that are used during surgeries to control the bleeding of the patient.

What is the CAGR of the Hemostats Market?

The Hemostats Market is expected to exhibit a strong 6.4% CAGR over the forecast period from 2018 to 2023.

What is the major driver for the Hemostats Market?

Growing number of surgical procedures around the world is the major driver for the hemostats market.

Which is the leading regional Hemostats Market?

Americas hold the major share in the hemostats market, followed by Europe.

What are the leading Hemostats Market players?

Leading players in the Hemostats Market include C.R. Bard, Stryker, and Pfizer, among others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Hemostats Market, by Product Type

6.1 Introduction

6.2 Thrombin based